Image Source: AsiaOne
RoosterBio Collaborates with Sartorius to Expand Cell and Gene Therapy Manufacturing Platform Technology into South KoreaThe partnership launches RoosterBio’s first international platform with off-the-shelf working cell banks and hMSC bioprocess media products in AsiaGlobeNewswireDecember 02, 2020FREDERICK, Md., Dec. 02, 2020 (GLOBE NEWSWIRE) -- RoosterBio, Inc, a leading supplier of innovative cellular therapy bioprocess tools and scalable manufacturing solutions for regenerative medicine, today announced it entered into an exclusive agency agreement with Sartorius Korea Biotech, a subsidiary of the Sartorius Group, a leading international partner of the biopharmaceutical and life science research sectors.
Source: AsiaOne